返回
Virus-like siRNA construct dynamically responsive to sequential microenvironments for potent RNA interference
DOI:10.1016/j.jcis.2022.05.006.png)
摘要
En 中文
Cytoplasmic transportation of therapeutic nucleic acids is deemed as an onerous task with aim of precise knockdown towards the targeted genes. Pertaining to the programed functionalities of natural virus in circumventing the biological barriers, we tailored multifaceted chemistries into manufacture of synthetic siRNA delivery vehicles in resembling the functionalities of viral vectors to dynamically tackle with a sequential of biological obstacles encountered in the journey of systemic anti-tumor RNAi therapy. Once harnessing ligands with RGD motif for specific internalization into subcellular endosomal compartments of the tumor cells, the architecture of the proposed delivery vehicles was subjected to facile transformation responsive to pH stimuli in acidic endosomal compartments. The external biocompatible PEGylation palisade was consequently detached, unveiling the cytomembrane-lytic cationic components to commit disruptive potencies to the anionic endosomal membranes for translocation of siRNA conjugates into cytosol. Eventually, liberation of active siRNA could be accomplished due to its responsiveness to the strikingly high level of glutathione in cytosol, thereby contributing to potent RNAi. Hence, our elaborated virus-mimicking platform has demonstrated significant anti-tumor efficacy through systemic administration of anti-angiogenic RNAi payloads, which inspired prosperous potentials in a variety of therapeutic applications.(c) 2022 Elsevier Inc. All rights reserved.
Keyword:
siRNA
pH responsive
Redox responsive
Nanomedicine
Anti-angiogenesis
期刊
IF:
9.7
论文数:
3.7W
被引数:
14.7W
机构
引用论文
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review肿瘤血管通透性和EPR在大分子治疗中的作用: 综述
Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors
BIOMATERIALS
IF12.9
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisPatisiran,一种RNAi治疗药物,用于遗传性转甲状腺素蛋白淀粉样变性

